ConocoPhillips (YCP)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 128.28 |
|---|---|
| 52-week range | 74.41 – 132.00 |
| Return, 1 month / 3 months | +15.7% / +23.7% |
| Return, 1 year / 3 years | +75.7% / +18.1% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 33.0% |
| Worst drawdown (1 year) | -24.0% |
| Average daily value traded | 0.10M EUR |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ConocoPhillips is an energy company based in the United States that explores for, produces and markets crude oil, natural gas and natural gas liquids. It operates in resource-rich regions around the world, from North America to Asia and Europe, and its customers include refiners, industrial users and energy traders. The company also has interests in oil sands and liquefied natural gas projects, and it manages a portfolio of long-life assets across several countries.
On this site ConocoPhillips appears as a stock on the XETRA Stock Exchange (Germany), code YCP, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ConocoPhillips (YCP) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 128.28 on 22 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 57 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 75.7% and over the last three months it rose 23.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 24.9% | ||
| From 52-week high | -1.2% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.7% | ||
| 6-month return | 24.7% | ||
| 12-month return, skipping the last month | 51.8% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.0% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.10M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +15.7% |
| 3 months | +23.7% |
| 6 months | +24.7% |
| 1 year | +75.7% |
| 3 years | +18.1% |
| 5 years | +133.3% |
Signals
| 50-day / 200-day average | 116.89 / 102.73 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.77 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Aug 2026 | USD 0.7472 |
| 11 May 2026 | USD 0.7472 |
| 18 Feb 2026 | USD 0.7472 |
| 17 Nov 2025 | USD 0.7472 |
| 18 Aug 2025 | USD 0.6938 |
| 19 May 2025 | USD 0.6938 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.